Costs of giving out free nicotine patches through a telephone quit line

Journal of Public Health Management and Practice

Volumn 17, Issue 3, 2011, Pages

  Cummings, K Michael ^a   Hyland, Andrew ^a   Carlin Menter, Shannon ^a   Mahoney, Martin C ^a   Willett, Jeffrey ^b   Juster, Harlan R ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Tobacco Surveillance Evaluation and Research ^*  (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Nicotine replacement therapy; randomized clinical trial; smoking cessation; telephone quit line

Indexed keywords

NICOTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COUNSELING; ECONOMICS; FEMALE; HEALTH PROMOTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TELEPHONE; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; COUNSELING; FEMALE; HEALTH PROMOTION; HOTLINES; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKING CESSATION; TOBACCO USE DISORDER; TRANSDERMAL PATCH; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955071663     PISSN: 10784659     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHH.0b013e3182113871     Document Type: Article

References (19)

1. Cummings KM, Hyland A. Impact of nicotine replacement therapy on smoking behavior. Ann Rev Public Health. 2005;26:583-599. (Pubitemid 40547397)
2. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Dept of Health and Human Services, Public Health Service; 2008.
3. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008; (1): CD000146.
4. Cummings KM, Hyland A, Fix B, et al. Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med. 2006;31:181-184. (Pubitemid 43994372)
5. Cummings KM, Mahoney MC. Strategies for smoking cessation: what is new and what works? Expert Rev Respir Med. 2008;2(2):201-213. (Pubitemid 351982830)
6. An L, Schillo BA, Kavanaugh AM, et al. Increased reach and effectiveness of a statewide tobacco Quitline after the addition of access to free nicotine replacement. Tobacco Control. 2006;15:286-293. (Pubitemid 44187514)
7. Cummings KM, Fix B, Celetino P, et al. Reach, efficacy, and cost-effectiveness of free nicotine medication give away programs. J Public Health Manag Pract. 2006;12:37-43. (Pubitemid 44132844)
8. Miller N, Frieden TR, Liu SY, et al. Effectiveness of a large-scale free nicotine patch distribution program. Lancet. 2005;365:1849-1854. (Pubitemid 40744961)
9. Kozlowski LT, Giovino GA, Edwards B, et al. Adviceonusing over-the-counter nicotine replacement therapy-patch, gum, or lozenge to quit smoking. Addict Behav. 2007;32(10):2140-2150. (Pubitemid 47198957)
10. McAfee T, Bush T, Deprey TM, et al. Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks. Am J Prev Med. 2008;35(2):103-110. (Pubitemid 351927269)
11. Campbell SL, Lee L, Haugland C, et al. Tobacco quitline use: enhancing benefit and increasing abstinence. Am J Prev Med. 2008;38(4):386-368.
12. Cummings KM, Fix BV, Celestino P, et al. Does the number of free nicotine patches given to smokers calling a quitline influence quit rates: results from a quasi-experimental study. BMC: Public Health. 2010;10:121.
13. Giovino GA, Chaloupka F, Hartman AM, et al. Cigarette Smoking Prevalence and Policies in the 50 States: An Era of Change-The Robert Wood Johnson Foundation Impac Teen Chart Book. Buffalo, NY: University at Buffalo, State University of New York; 2009.
14. Johnston EC, Yudkin PL, Hey K, et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics. 2004;14:83-90. (Pubitemid 38253643)
15. Lerman C, Tyndale RF, Patterson F, Wileyto EP, Pinto N, Benowitz N. Nicotine metabolite ratio predicts the efficacy of transdermal nicotine in a smoking cessation randomized clinical trial. Clin Pharmacol Ther. 2006;79:600-608. (Pubitemid 43817942)
16. Seller EM, Kaplan HL, Tyndale RF. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking. Clin Pharmacol Ther. 2000;68:35-43. (Pubitemid 30609825)
17. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. JAMA. 1995;274:135-138.
18. Schnoll RA, Patterson F, Wileyto EP, et al. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med. 2010;152:1-38.
19. Ossip-Klein DJ, McIntosh S. Quitlines in North America: evidence base and applications. Am J Med Sci. 2003;326:201-205. (Pubitemid 37271393)